ストックスクリーナーアプリを入手
4.05
14.73%
0.52
前日終値:
$3.53
開ける：
$3.49
24時間の取引高:
14,238
Relative Volume:
1.32
時価総額：
$32.62M
収益：
$31.28M
当期純損益:
$-2.67M
株価収益率:
-12.22
EPS:
-0.3315
ネットキャッシュフロー:
$4.94M
1週間 パフォーマンス:
+11.52%
1か月 パフォーマンス:
+14.08%
6か月 パフォーマンス:
+8.00%
1年 パフォーマンス:
-21.28%
1日の値動き範囲:
$3.46
$4.05
1週間の範囲:
$3.34
$4.05
52週間の値動き範囲:
$2.72
$6.35
Cryo Cell International Inc Stock (CCEL) Company Profile
名前
Cryo Cell International Inc
セクター
電話
813 749 2100
住所
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 5.10 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.38 | 3.16B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.54 | 425.01M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.909 | 269.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.61 | 0 | 0 | 0 | 0 | 0.00 |
Cryo Cell International Inc (CCEL) 最新ニュース
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Cryo-Cell International Inc (CCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cryo-Cell International Inc (CCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cryo-Cell International Inc (CCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cryo-Cell International Inc (CCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cryo-Cell International Inc (CCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cryo-Cell International Inc (CCEL) Institutional Confidence - TradingKey
Cryo-Cell International Inc (CCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cryo-Cell International Inc (CCEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cryo-Cell International Inc (CCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
World Cryo-Preservation Vial SystemMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Number of shareholders of Cryo-Cell International, Inc. – AMEX:CCEL - TradingView
Number of shareholders of Cryo-Cell International, Inc. – SWB:ZCY - TradingView
Cryo-Cell International, Inc. Financial Disclosures & SEC Filings - TradingView
Cryo-Cell International (CCEL) Tumbles 5.99% as Shares Test Key Support at $3.28Stock News - newsline.com
CCEL Q1 2026 Earnings: EPS Surges Past Estimates, Driving Stock HigherFinancial Summary - newsline.com
CCEL Q1 2026 Earnings: Positive EPS Surprise Defies EstimatesEPS Miss Report - newsline.com
CCEL Q1 2026 Earnings: EPS Surprise Beats Estimates as Company Shows ProfitabilityEarnings Revision Report - newsline.com
CCEL Q1 2026 Earnings: EPS Surprises to the Upside, Recording a Profit Against ExpectationsPre-Earnings Drift - newsline.com
LYFT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
[Form 4] CRYO CELL INTERNATIONAL INC Insider Trading Activity - Stock Titan
Cryo-Cell International (CCEL) Surges 6.78%: Key Levels and Momentum AnalysisUp Down Ratio - thelegaladvocate.com
Cryo-Cell International (CCEL) Holds Near Support Amid Quiet TradingTrend Following Picks - The Legal Advocate
CCEL Q1 2026 Earnings: Earnings Beat Expectations with Positive EPSEarnings Preview - The Legal Advocate
Cryo-Cell (CCEL) Q1 2026 Earnings: Why the Beat MattersProfit Inflection Point - The Legal Advocate
Cryo-Cell International (CCEL) Short Interest & Short Float | Updated May 2026 - MarketBeat
TradingKey - TradingKey
Cryo-Cell International FY Net Income USD -2. - Moomoo
Cryo-Cell Plan Accepted to Regain NYSE Compliance - The Globe and Mail
How Cryo-Cell (CCEL) is positioning for the next five years (Weakens) 2026-05-08Community Pattern Alerts - newser.com
Cryo-Cell International’s Compliance Plan Accepted by NYSE American - geneonline.com
NYSE accepts Cryo-Cell plan to regain listing compliance By Investing.com - Investing.com Australia
NYSE accepts Cryo-Cell plan to regain listing compliance - Investing.com
Cryo-Cell Gets NYSE American Approval for Compliance Plan - Moomoo
Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American - The Joplin Globe
NYSE American accepts Cryo-Cell (NYSE: CCEL) plan to regain compliance - Stock Titan
How Cryo-Cell (CCEL) performance compares to expectations (+1.42%) 2026-05-08Bearish Pattern - newser.com
Cryo-Cell receives renewed FACT accreditation through 2029 By Investing.com - Investing.com Nigeria
Cryo-Cell receives renewed FACT accreditation through 2029 - Investing.com
Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks - Business Wire
Emerging Sub-Segments Transforming the Stem Cell and Cord Blood Banking Market Landscape - openPR.com
CCEL (Cryo-Cell International Inc.) posts positive Q1 2026 EPS against expected loss, shares rise modestly.Seasonality - Xã Thanh Hà
Cryo-Cell (CCEL) Market Dynamics | Q1 2026: Better Than ExpectedIPO - Cổng thông tin điện tử tỉnh Lào Cai
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
Cryo-Cell International Faces NYSE American Compliance Review and Potential Delisting Risk Ahead of 2027 Deadline - The Globe and Mail
CCEL Reports Drop in Q1 Revenue Compared to Last Year - GuruFocus
CRYO Cell International Q3 10-Q: Revenue $7.68M, Cost of Sales $1.66M - TradingView
[10-Q] CRYO CELL INTERNATIONAL INC Quarterly Earnings Report - Stock Titan
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results - Bluefield Daily Telegraph
Cryo Cell International Inc (CCEL) 財務データ
収益
当期純利益
現金流量
EPS
Cryo Cell International Inc (CCEL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 16 '25 |
Buy |
4.46 |
6,449 |
28,763 |
818,369 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 17 '25 |
Buy |
4.43 |
5,564 |
24,649 |
823,933 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 18 '25 |
Buy |
4.46 |
3,411 |
15,213 |
827,344 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 18 '25 |
Buy |
4.49 |
1,751 |
7,862 |
161,833 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 10 '25 |
Buy |
4.44 |
25,139 |
111,692 |
268,878 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 10 '25 |
Buy |
4.42 |
7,178 |
31,727 |
811,920 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 09 '25 |
Buy |
4.49 |
5,312 |
23,849 |
257,843 |
| PORTNOY DAVID | Chairman, Co-CEO |
Sep 08 '25 |
Buy |
4.31 |
5,271 |
22,718 |
253,028 |
| PORTNOY DAVID | Chairman, Co-CEO |
Aug 25 '25 |
Buy |
4.61 |
14,000 |
64,560 |
241,539 |
| PORTNOY DAVID | Chairman, Co-CEO |
Aug 27 '25 |
Buy |
4.43 |
14,078 |
62,349 |
247,757 |
0.63%
0.06%
大文字化:
|
ボリューム (24 時間):